Biotech

All Articles

Biogen, UCB file stage 3 lupus win after stopping working earlier trial

.Biogen and UCB's depend developing right into stage 3 astride a broken research tries to have actua...

Aptadir hopes new RNA inhibitors can reverse tricky cancers

.Italian biotech Aptadir Rehabs has actually released along with the pledge that its own pipe of pre...

Wave surfs DMD excellence to regulatory authorities' doors, delivering stockpile

.Wave Life Sciences has actually met its own target in a Duchenne muscle dystrophy (DMD) research, p...

Sanofi tweezes new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, occupying t...

Achilles drops cell treatment plan, prepares for layoffs after missing out on 'office feasibility' objectives

.Achilles Rehabs has actually shreded its own approach. The British biotech is stopping work on its ...

Aligos trumpets period 2 MASH win, lowering liver body fat approximately 46%

.Aligos Therapies is actually heralding a midstage gain in metabolic-dysfunction linked steatohepati...

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job cultivating brand-new antifungals has obtained a considerable improveme...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Possessing actually gathered up the united state rights to Capricor Therapeutics' late-stage Duchen...

FDA scraps adcomm for Applied's rare disease drug

.After pushing back the decision meeting for Applied Therapies' metabolic condition medicine govores...

Novo inks $600M NanoVation deal to study genetic medicines ex-liver

.Novo Nordisk is continuing its own push into hereditary medications, accepting to compensate NanoVa...